Skip to content
October 04, 2022

Equity.Guru

Investment information for the new generation

mindmed peyote

In a groundbreaking story MindMed (MNMD.Q) announced today has been granted approval by the Swiss Ethics Committee to evaluate the acute effects of different doses of mescaline and the…